Small cap₹310 cr₹0.8 cr traded a dayThin: a ₹2 lakh order is 2.6% of a normal day
Close on 11 September 2026
1.65
+4.43%
52-week range64% of the way up
0.492.30
Market cap
310 cr
P/E (TTM)
246.8×
EPS (TTM)
0.01
Revenue YoY
+39.8%
Q1 FY27
Profit YoY
-33.9%
Net margin
1.4%
-1.5pt vs a year ago
Growth trend
-16.0pt
vs last quarter’s YoY
1 month
+12.2%
Below 52w high
28.3%
RSI (14)
69
Daily swing
5.2%
average true range
Volume
0.1×
vs 20-day average
Traded
₹1 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Above the median
+14.4%
One-year return
Below the median
-24.3%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
3 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
+39.8%
Below the 52-week high
distance from the highest close of the year
28.3%
How it has performed
price return over each window, beside the median NSE stock over the same days
The read
written from the numbers on this page
More of the measured facts point up than down4 supporting, 2 against, 0 worth knowing
Supporting
trading 14% above its 200-day average
4 independent kinds of evidence agree today, which is uncommon
revenue grew 40% year on year in the quarter ending 30 June 2026
net margin has widened from -0.9% to 1.4% across four quarters
Against
down 24% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
The market itself is rangebound tonight. Each scan's record is measured separately for this regime; the figure beside each chip above is the one that applies, not the all-weather number.
What would change these counts: the close crossing its 200-day average, which is 1 tonight and moves every session.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Revenue +39.8% year on year, Rs 22 cr to Rs 31 cr.
+39.8%Rs 22 crRs 31 cr
Trading 14.4% above its 200-day simple average, which is the line most investors use to separate a bull phase from a bear one.
+14.4%
4 different kinds of evidence point at it tonight, not 4 versions of the same one.
4 families
Needs watching6
Profit grew slower than revenue, -33.9% against +39.8%.
-33.9%+39.8%
Net profit -33.9% year on year, Rs 1 cr to Rs 0 cr.
-33.9%Rs 1 crRs 0 cr
Net margin moved from 2.9% to 1.4%.
2.9%1.4%
28% below its 52-week high.
-28%
Down 24.3% over the past year.
-24.3%
Only ₹0.8 crore changes hands on a median day. A large order moves this price by itself.
₹0.8 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. The wording is generated directly from the figures.
What the scans say today
6 of 57 matched on 11 Sep
EVEXIA matches 6 of the 57 scans today, across 4 different kinds of evidence (not counting 1 that match most of the market tonight). Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses. It is in none of the 19 published portfolios on the arena tonight.
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 40% against the same quarter a year earlier
Going against it
profit dropped 34% year on year
net margin narrowed from 2.1% to 1.4%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
31
1
0
0.00
1.4%
Q4 FY26
31 Mar · consolidated
37
1
1
0.00
2.1%
Q3 FY26
31 Dec · consolidated
25
0
0
0.00
1.2%
Q2 FY26
30 Sep · consolidated
26
0
0
0.00
-0.9%
Q1 FY26
30 Jun · consolidated
22
1
1
0.03
2.9%
Q4 FY25
31 Mar · consolidated
24
0
0
0.00
1.3%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Valuation against its own history
140 sessions since 18 February 2026
107×
median 208×
286×
now 247×
EVEXIA trades at 247× trailing earnings, above its median of 208× over this window — 19% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
How it is priced against the universe
tonight’s multiples, ranked against every company we scan
Measure
Tonight
Where it ranks
Price to earnings
trailing four quarters of profit
246.8×
cheaper than 3% of scanned companies
Price to sales
trailing four quarters of revenue
2.61×
cheaper than 47% of scanned companies
Earnings yield
0.4%
profit as a share of the market value — the P/E upside down
Value composite
75
average percentile across the three multiples; 0 is the cheapest company scanned, 100 the dearest
Quality checklist
five of Piotroski’s nine tests, the ones Indian filings support
2 of 5
✓ profitable over four quarters✗ cash conversion above 100%✗ borrowings under half of equity✗ margin up on a year ago✓ revenue up on a year ago
A low multiple is a statement about expectations, not about quality: the market usually expects less from a cheap company, and is often right. These are rankings, not fair values.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726) · Board meeting filings were typically +0.02pt vs the market over the next 5 sessions (n=6,172)
Who bought size here
bulk and block deals disclosed to NSE and BSE, internal transfers removed
Over the last 40 sessions the disclosed tape in EVEXIA reads Creeping accumulation: buying dominated on 3 sessions and selling on 0, of 6 with any disclosure. Net +87,954,891 shares (+4.69% of the equity), ₹12.6cr at the prices dealt. The largest buyer was SHREE SAIBABA EXIM PRIVATE LIMITED, a company, on 3 separate sessions. The stock has moved +18.7% since the first of these deals.
Session by session, last 40 sessions · up and green when more shares were bought than sold, down and red when more were sold, a flat mark where nothing was disclosed
20 Jul11 Sep
Session
Side
Counterparty
Shares
Price
Value
10 Sep
Bought
SHREE SAIBABA EXIM PRIVATE LIMITED
body corporate · BSE
13,817,760
1.58
₹2.2cr
8 Sep
Bought
SHREE SAIBABA EXIM PRIVATE LIMITED
body corporate · BSE
38,269,858
1.44
₹5.5cr
4 Sep
Bought
SETU SECURITIES PVT LTD
broker · BSE
25,000,000
1.27
₹3.2cr
4 Sep
Sold
NISHCHAYA TRADINGS PRIVATE LIMITED
body corporate · BSE
9,515,948
1.25
₹1.2cr
3 Sep
Sold
NISHCHAYA TRADINGS PRIVATE LIMITED
body corporate · BSE
25,000,000
1.27
₹3.2cr
3 Sep
Bought
MANSI SHARE AND STOCK BROKING PRIV
broker · BSE
15,700,000
1.27
₹2.0cr
3 Sep
Sold
SILVERTOSS SHOPPERS PRIVATE LIMITE
body corporate · BSE
10,043,529
1.28
₹1.3cr
2 Sep
Bought
SHREE SAIBABA EXIM PRIVATE LIMITED
body corporate · BSE
20,395,000
1.36
₹2.8cr
2 Sep
Bought
MANSI SHARE AND STOCK BROKING PRIV
broker · BSE
10,000,000
1.38
₹1.4cr
2 Sep
Bought
F3 ADVISORS PRIVATE LIMITED
body corporate · BSE
10,000,000
1.38
₹1.4cr
1 Sep
Sold
ALTIZEN VENTURES LLP
body corporate · BSE
14,068,250
1.46
₹2.1cr
1 Sep
Bought
MANSI SHARE AND STOCK BROKING PRIV
broker · BSE
13,400,000
1.46
₹2.0cr
How to read this. A bulk deal is a single trade of more than half a percent of the company’s shares; a block deal is a large trade negotiated off the order book. Both must be disclosed the same day, with the counterparty’s name. When the same name appears on both sides of the same stock on the same day it is an internal transfer and is removed before anything here is counted. Who the counterparty is comes from its name and is a guess. Across every disclosed buy on file, the stock was +0.09% against the market 20 sessions later on average, ahead of it 41% of the time, over 1,370 deals. After a disclosed sell: -1.34% against the market, ahead 41% of the time, 1,439 deals. A disclosure says what someone did, not why, and nothing here says what happens next. Full tape on the Who bought size page.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+9.9%
Versus 200-day average+14.4%
Below 52-week high28.3%
Above 52-week low+236.7%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)68.8
Higher closes in last 55 of 5
Six-month return+12.24%
Risk and liquidity
What a position costs to hold and to exit. Delivery is the share of the day’s volume taken into demat rather than squared off; trade size says whether the day’s tickets were large or small.
Typical daily swing (ATR)5.19%
What ₹1 lakh here moves on a normal dayabout ₹5,195
Volume versus 20-day0.1x
Median daily turnover₹0.8 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.